Nature Reviews. Molecular Cell Biology | Sources of False Negatives in RNA Modification Studies and Mitigation Strategies

This article systematically summarizes the major technical and biological sources of false negatives in RNA modification sequencing studies and proposes practical recommendations for improving detection sensitivity and data transparency, offering significant guidance for accurately mapping the epitranscriptomic modification landscape.

 

Literature Overview

The article, 'All the sites we cannot see: sources and mitigation of false negatives in RNA modification studies,' published in Nature Reviews. Molecular Cell Biology, reviews and summarizes the systematic false-negative issues currently faced by RNA modification sequencing technologies in identifying modification sites across the transcriptome. The authors provide a detailed analysis of technical blind spots throughout the workflow—from sample preparation and library construction to data analysis—that may lead to missed modification sites, and propose corresponding optimization strategies and reporting standards. The study emphasizes that although RNA modifications play critical roles in human health and disease, existing modification maps remain preliminary drafts, and false-negative results due to technical biases should be carefully guarded against. The article calls on researchers to fully consider detection sensitivity and coverage in experimental design and data interpretation to achieve more complete and accurate RNA modification mapping.

Background Knowledge

RNA modifications are a key mechanism of post-transcriptional regulation. Over 170 chemical modifications have been identified to date, including m6A, ac4C, and m1A, which are widely involved in RNA splicing, stability, translation, and subcellular localization. These modifications are dynamically regulated by 'writer,' 'eraser,' and 'reader' proteins, and their dysregulation is closely linked to various diseases such as neurodevelopmental disorders and cancer. In recent years, high-throughput sequencing-based RNA modification mapping has rapidly advanced, primarily including antibody enrichment methods (e.g., MeRIP-seq) and chemical conversion methods (e.g., bisulfite-seq, ac4C-seq). However, these methods commonly suffer from both false-positive and false-negative results. False negatives are particularly difficult to detect and may lead to the systematic omission of key modification sites, thereby impairing a comprehensive understanding of modification functions. Current mainstream technologies face numerous challenges: short-read sequencing struggles to span modification-enriched regions, RNA secondary structures affect antibody binding and chemical reaction efficiency, variable responses of reverse transcriptases to modified nucleotides result in signal loss, and insufficient sequencing depth. Moreover, poor reproducibility across laboratories is partly due to the lack of standardized sensitivity assessments and transparent reporting. Therefore, systematically identifying the sources of false negatives and proposing actionable optimization strategies is crucial for enhancing the reliability and comparability of RNA modification research. This study focuses on the long-overlooked issue of false negatives, providing solutions from a full-experimental workflow perspective, thereby filling a critical methodological guidance gap in the field.

 

 

Research Methods and Experiments

This article employs a combination of literature review and methodological analysis to systematically examine the technical factors contributing to false negatives in RNA modification sequencing studies. The authors begin with general issues in RNA-seq workflows, including insufficient sequencing depth, preferential loss of RNA during isolation (e.g., loss of small or non-poly(A) RNAs due to Trizol or oligo(dT) enrichment), and the discarding of multi-mapping reads during alignment. Subsequently, the article delves into biases specific to RNA modification detection methods, such as differential sensitivity of RNA fragmentation to modifications (e.g., Nm resistance to alkaline cleavage versus easy breakage of dihydrouridine), variable responses of reverse transcriptases to different modifications (e.g., m1A causing RT termination or misincorporation), and sequence preferences during adapter ligation in library construction. For antibody-based enrichment, the authors discuss antibody specificity, modification accessibility (influenced by RNA structure), and signal-to-noise ratio; for chemical conversion methods, they focus on conversion efficiency, sequence context dependency during reverse transcription, and limitations of negative control treatments. The article also emphasizes the importance of using synthetic RNA standards, UMI molecular tags, and biological replicates.

Key Conclusions and Perspectives

• False negatives in RNA modification sequencing are widespread and primarily stem from systematic biases in the technical workflow, rather than random errors
• Sequencing depth directly affects the ability to detect modification sites in low-abundance transcripts; appropriate depth should be set according to research goals, with coverage clearly reported
• RNA isolation methods (e.g., oligo(dT) vs. ribodepletion) significantly impact the detection of 5' end modifications; ribosomal RNA depletion combined with total RNA sequencing is recommended to improve comprehensiveness
• The choice of reverse transcriptase is critical; high-processivity enzymes (e.g., TGIRT) can reduce premature cDNA synthesis termination caused by RNA structure or modifications
• Antibody enrichment methods are limited by antibody specificity and modification accessibility; heating can improve structural occlusion but may compromise RNA integrity
• Chemical conversion efficiency is affected by RNA structure and sequence context; synthetic standards should be used to assess and report conversion efficiency
• Negative control treatments (e.g., enzymatic or chemical demodification) are often incomplete, potentially leading to the erroneous filtering out of true modification sites
• UMIs are recommended to distinguish PCR duplicates from genuine transcripts, and biological replicates should be used to enhance statistical power
• Standardized sensitivity assessment protocols should be established, with the proportion of assessable sites clearly reported, avoiding equating 'undetected' with 'unmodified'
• Future studies should combine multiple technologies (e.g., nanopore sequencing, in vivo metabolic labeling) to leverage complementary advantages and obtain more complete modification maps

Research Significance and Prospects

This study profoundly reveals the long-neglected issue of false negatives in RNA modification sequencing, providing researchers with a systematic risk assessment framework and experimental optimization strategies. By identifying technical blind spots from sample preparation to data analysis, the article lays a methodological foundation for improving the accuracy and reproducibility of RNA modification maps. The transparent reporting standards emphasized by the authors (e.g., coverage statistics) will facilitate reasonable comparisons across studies and drive the field toward greater rigor.

Looking ahead, as single-molecule direct RNA sequencing (e.g., Nanopore) matures, it may bypass reverse transcription and PCR amplification steps, directly reading modification signals and thereby significantly reducing false negatives. Simultaneously, developing more efficient chemical probes and highly specific antibodies, combined with in vivo metabolic labeling techniques, will yield modification maps closer to physiological conditions. Additionally, integrating multi-omics data (e.g., RBP binding, translation efficiency) will help decipher the functional consequences of modifications. Overall, this review provides essential quality control guidelines for epitranscriptomic research, promoting a deeper shift from 'discovering modifications' to 'understanding function'.

 

 

Conclusion

This article comprehensively analyzes the primary sources of false negatives in RNA modification sequencing studies, covering every step from RNA extraction and fragmentation to reverse transcription and sequencing data analysis. The authors highlight that 'blind spots' caused by technical biases lead to systematic omissions in current modification maps, particularly for low-abundance transcripts, 5' terminal regions, and sites protected by RNA structure. By comparing the two mainstream approaches—antibody enrichment and chemical conversion—the article reveals their distinct mechanisms of false negatives and proposes specific solutions, including optimizing sequencing depth, using high-processivity reverse transcriptases, adopting ribosomal RNA depletion strategies, and incorporating UMIs and synthetic standards. Most importantly, the study calls for establishing standardized sensitivity assessments and transparent reporting systems to clearly distinguish between 'undetected' and 'unmodified' states. This framework not only enhances the reliability of existing technologies but also points the way toward developing more precise modification detection methods in the future. With technological advancements and improved standards, we can expect more complete and accurate RNA modification maps, enabling a deeper understanding of their complex roles in gene expression regulation and human diseases.

 

Shalini Oberdoerffer and Wendy V Gilbert. All the sites we cannot see: sources and mitigation of false negatives in RNA modification studies. Nature reviews. Molecular cell biology.